Cargando…
Predictive value of early molecular response for deep molecular response in chronic phase of chronic myeloid leukemia
To investigate the association of 3- and 6-month BCR-ABL transcript levels on the international scale (BCR-ABL(IS)) and other factors with deep molecular response (DMR) achievement in chronic myeloid leukemia (CML)-chronic phase (CP) patients receiving tyrosine kinase inhibitor (TKI) therapy. We ret...
Autores principales: | Wang, Rui, Cong, Yue, Li, Caili, Zhang, Chen, Lin, Hai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485861/ https://www.ncbi.nlm.nih.gov/pubmed/30985724 http://dx.doi.org/10.1097/MD.0000000000015222 |
Ejemplares similares
-
Early dynamics of chronic myeloid leukemia on nilotinib predicts deep molecular response
por: Okamoto, Yuji, et al.
Publicado: (2022) -
Deep molecular responses for treatment‐free remission in chronic myeloid leukemia
por: Dulucq, Stéphanie, et al.
Publicado: (2016) -
Molecular response in newly diagnosed chronic-phase chronic myeloid leukemia: prediction modeling and pathway analysis
por: Radich, Jerald P., et al.
Publicado: (2023) -
Combination of White Blood Cell Count at Presentation With Molecular Response at 3 Months Better Predicts Deep Molecular Responses to Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Patients
por: Qin, Ya-Zhen, et al.
Publicado: (2016) -
Why is it critical to achieve a deep molecular response in chronic myeloid leukemia?
por: Branford, Susan
Publicado: (2020)